论文部分内容阅读
近年,应用射频消融(RFA)治疗结肠癌肝转移(CRLM)逐渐增多。单独RFA或联合应用可提高不可切除CRLM的疗效,尤其对于直径<3 cm转移灶的疗效已经得到肯定。RFA提高了不可切除CRLM的总体疗效,但仍需要随机大样本循证医学证据,其疗效依赖于RFA技术水平的提高及医生经验的不断积累。
In recent years, the application of radio frequency ablation (RFA) treatment of colon cancer liver metastases (CRLM) increased. The efficacy of unresectable CRLM alone or in combination with RFA alone has been confirmed, especially for those with metastases <3 cm in diameter. RFA improves the overall efficacy of unresectable CRLM, but randomized large-sample evidence-based medicine is still needed and its efficacy relies on the increased level of RFA technology and the accumulation of physician experience.